NOTICIAS
- Immune cell circuit restores barrier function in inflammatory bowel disease
- Mapping immune cell interactions in gut tissue reveals changes in ulcerative colitis
- An intranasal flu vaccine approved two decades ago may have underappreciated immune benefits
- Asthma attacks reshape airway tissue through mechanical stress, lung-on-a-chip reveals
- Genetic cause for rare skin condition points to new therapeutic option
- Target with potential to improve CAR T-cell therapy response in patients with blood cancers identified
- Crohn’s atlas maps gene shifts across more than 50 gut cell types
- Immune activation may determine success of dual-target CAR T therapy in glioblastoma
- Why some immunotherapy fails: Tumor-triggered neutrophils can shut down cancer-killing T cells
- In vivo CRISPR therapy successfully reduces hereditary angioedema attacks in first Phase III trial
- Killing cancer requires immune cells to infiltrate tumors’ hostile microenvironment—sugar shields can help them break in
- What to know about alpha-gal syndrome, the life-threatening meat allergy caused by tick bites
- Sugar-coated CAR-T cells survive longer and shrink lymphoma tumors in mice
- Severe COVID-19 reveals distinct immune patterns tied to metabolism, not just antiviral response
- Flu infection may weaken tuberculosis defenses by disrupting key immune pathways
- Can fasting fight gum disease? Scientists find surprising link
PUBLICACIONES
- Engineering human synovial organoids as predictive ecosystems for disease modeling and therapeutic response in rheumatology
- T cell control of the intestinal barrier and gut microbiota during ageing. Manuel M Gómez de Las Heras
- Correction: MAPRE2 is associated with macrophage-enriched innate immune dysregulation and malignant phenotypes in hepatocellular carcinoma
- Correction: The association between systemic lupus erythematosus and cognitive impairment or dementia: a meta-analysis
- Correction: VTX-PID as a novel recombinant immunoglobulin G–degrading enzyme (IdeS) for efficient AAV-based gene therapy in participants with neutralizing antibodies: results of the phase I first-in-human NAVIgATE study
- Correction: The relationship of chemokine levels and the type of symptoms caused by NSAIDs or alcohol in patients with NSAIDs-exacerbated respiratory disease
- Fusion protein-mediated costimulation in engineered T cells: from intrinsic signaling to tumor microenvironment rewiring
- Accelerated immunosenescence in SLE: current evidence and clinical translation
- Mechanisms outpacing medicine in autoinflammatory diseases
- Distinct IgM and IgG autoantibody profiles characterize incomplete and classified systemic autoimmune diseases
- Autoantibody-mediated pain in long COVID: evidence from multiple lines
- Editorial: Immune-related biomarkers in skin and breast cancer: innovations in immunological diagnostics and therapies
- Editorial: Biomarkers and beyond: predicting course and tailoring treatment in inflammatory bowel diseases
- CX3CR1 and CCR2: dynamic myeloid cell states across inflammatory diseases with implications for oral health and disease
- The role of Astragalus membranaceus and its derivatives in digestive system diseases: reconstruction of immune tolerance
- The gut-liver-kidney-brain axis in Wilson disease: copper speciation-flux and barrier-mediated organ crosstalk
- Microbiota metabolite butyrate alleviates intestinal inflammation associated with enhanced autophagy-related signaling in DSS-induced colitis
- Case report: Recurrence of anti-myeloperoxidase pauci-immune crescentic glomerulonephritis in a kidney transplant recipient; potential association with HLA antigens and seropositivity?
- Cardiovascular sequelae of Long COVID: immune dysregulation inflammation as central drivers
- FcγRIIA signalling as a host-associated determinant of endosomal trafficking and antibody-dependent enhancement in flavivirus infection
- Conversion-oriented multimodal therapy enabling definitive surgery in a patient with FIGO stage IVA cervical cancer at high risk of fistula formation: a case report
- Targeted replacement of human γδ TCR in mice enhances antigen-specific B cell immunity
- Development of bispecific antibodies with enhanced neutralization activity against tested SARS-CoV-2 Omicron subvariants
- The regulatory roles of dysregulated lactate dehydrogenase A in anti-tumor immunity within immune cells
- Epstein–Barr virus-driven immunosuppression in nasopharyngeal carcinoma: a comprehensive review of viral mechanisms, spatial tumor ecosystems, and precision therapeutics
- Unveiling natural anti-inflammatory compounds for sinusitis treatments by modulating FOXP3, C5aR1, and LIF
- A transcriptome-defined TAM-rich phenotype identifies a macrophage-enriched, hypoxia-linked immune contexture in glioblastoma: multi-cohort transcriptomic validation and local histopathological correlation
- Enhancing immunotherapy efficacy in multiple myeloma and chronic lymphocytic leukemia: from combinatorial therapeutic approaches to gut microbiota modulation
- Severe renal and pancreatic toxicities associated with ipilimumab and nivolumab combination therapy in non-small cell lung cancer: a pharmacovigilance analysis of the FDA adverse event reporting system
- Case Report: Safety and efficacy of blinatumomab in combination with donor lymphocyte infusion for the prophylaxis of relapse following allogeneic hematopoietic stem cell transplantation in a pediatric patient with acute lymphoblastic leukemia
- Reprogramming dendritic cells to overcome tumor-mediated immune suppression
- The role of the bidirectional regulatory network between immune cells and stromal cells in cardiac repair and fibrosis following myocardial infarction